baber/WOPTO huggingface dataset:
Patent DE-69620364-T2 (DE)
Inventor: GONZENBACH HANS ULRICH
IPC: A61Q5/02
Filed: 1996-12-12
Granted: 2002-11-14
Abstract: Photostable, cosmetic light-screening composition, comprising, in a cosmetically acceptable vehicle containing at least one fatty phase, about 0,1 to about 5 %, in particular about 1 to about 3 % by weight, of a dibenzoylmethane type UV-A screening agent and at least about 0,5 %, in particular about 0,5 to about 4,5 % by weight, of a  alpha -cyano- beta , beta -diphenylacrylate stabiliser, the mole ratio of the acrylate to the dibenzoylmethane derivative being less than 0.8, if the amount of the dibenzoylmethane is 1% or more, and, optionally, at least one conventional UV-B filter.
Patent DE-69628301-T2 (DE)
Inventor: TAYLOR JOHN
IPC: C12P41/00
Filed: 1996-07-25
Granted: 2003-11-27
Abstract: PCT No. PCT/GB96/01813 Sec. 371 Date Dec. 23, 1997 Sec. 102(e) Date Dec. 23, 1997 PCT Filed Jul. 25, 1996 PCT Pub. No. WO97/05093 PCT Pub. Date Feb. 13, 1997A cycloalkanol is prepared by cycloaddition between a diene and a vinyl ester, wherein the ester is derived from a carboxylic acid of sufficient molecular weight to enable the reaction to be carried out at atmospheric pressure while above 150 DEG  C., and the corresponding reaction between the diene and vinyl acetate generates a pressure above 4 atmospheres.
Patent DE-69630771-T2 (DE)
Inventor: HOSOKAWA TERUO
IPC: C08K7/00
Filed: 1996-09-25
Granted: 2004-09-23
Abstract: A method of producing a resin composition containing an inorganic filler is disclosed, wherein organic cations having a steric hindrance structure are brought into contact with a layered mineral with an equivalent area per unit charge on the layer surface of 40-150  ANGSTROM <2>/charge, then brought into contact with a thermoplastic resin having a solubility parameter of at least 9.5 Äcal/cm<3>Ü<1/2>, so as to disperse the layered mineral inside the resin at the molecular level. The resin compositions obtained by this production method have excellent rigidity, heat resistance and impact resistance, and are suitable for use in fields such as, for example, automobiles, household electronic parts, construction materials and industrial materials.
Patent DE-69702822-T2 (DE)
Inventor: BOTMA HENDRIK
IPC: A47J37/08
Filed: 1997-03-27
Granted: 2001-03-15
Abstract: A Toaster having heating elements whose heating area depends on the slice size. A toaster has heating elements (H1, H2) divided into sub-elements (H1A, H1B; H2A, H2B) which can be activated individually. The size of the product to be toasted (5) is detected by means of a sensor, for example a mechanical sensor (2) or an optical sensor device with a photo-emitter and a photo-receiver. The sub-elements are activated selectively in dependence on the detected size. Thus, the power consumption of the toaster is adapted to the size of the product to be toasted and overheating of the product in the proximity of the unused heating area of the heating elements is avoided.
Patent DE-69703725-T2 (DE)
Inventor: SATAKE KUNIO
IPC: A61P31/04
Filed: 1997-08-28
Granted: 2001-04-26
Abstract: This invention provides a compound of the formula: <CHEM>  and its pharmaceutically acceptable salts, wherein R<1> is halo, C1-C6 alkyl, halo C1-C6 alkyl, C1-C6 alkoxy or halo C1-C6 alkoxy; R<2> is hydrogen, C1-C6 alkyl, halo C1-C6 alkyl, C1-C6 alkyl-S-, C1-C6 alkyl-SO-, C1-C6 alkyl-SO2-, cyclopropyl, phenyl, -NH2, -NH(CH3), -NHC(=O)CH3, -N(CH3)2, - N(C2H5)2 or -CH2C(=O)CF3; Ar<1> and Ar<2> are independently phenyl, halophenyl or thienyl; X is NH, O or S; and Y is hydrogen, -COOR<3> or -CONR<4>R<5>, wherein R<3>, R<4> and R<5> are independently hydrogen or C1-C6 alkyl. These compounds are useful as analgesics or anti-inflammatory agents, or in the treatment of allergic disorders, angiogenesis, CNS disorders, emesis, gastrointestinal disorders, sunburn, urinary incontinence, or diseases, disorders or adverse conditions caused by Helicobacter pylori, or the like, in a mammalian subject, especially human, especially as analgesics or anti-inflammatory agents in the periphery.
Patent DE-69704279-T2 (DE)
Inventor: MALCUS-VOCANSON CARINE
IPC: G01N33/50
Filed: 1997-09-12
Granted: 2001-10-31
Abstract: The invention proposes a method for detecting and/or quantifying, in a biological sample, a cytotoxic factor, in particular a gliotoxic factor, with respect to adherent target cells, in particular macroglial cells, the toxicity of which causes the death by apoptosis of said cells. The method comprises providing an initial fraction of the sample, optionally enriched with the toxic factor by previous treatment, incubating the initial toxic factor with a reference culture medium comprising adherent target cells, and detecting and/or quantifying in the adherent target cells killed by apoptosis, by flow cytometry, at least one direct or indirect characteristic associated with the apoptotic adherent cells of the whole or part of the incubated medium, which, if it is present and/or is quantified, qualifies the sample as positive, i.e. as containing said toxic factor. The initial biological sample is preferably a urine specimen.
Patent DE-69705388-T2 (DE)
Inventor: SALAKER ALLAN
IPC: B65H23/10
Filed: 1997-01-16
Granted: 2002-05-02
Abstract: PCT No. PCT/SE97/00055 Sec. 371 Date Sep. 25, 1998 Sec. 102(e) Date Sep. 25, 1998 PCT Filed Jan. 16, 1997 PCT Pub. No. WO97/26818 PCT Pub. Date Jul. 31, 1997A braking arrangement for dispensers of continuous material particulary paper dispensers includes a first gearwheel arranged for rotation about a first axis, and second gearwheel arranged for rotation about a second axis. The second gearwheel is arranged for displacement relative to the first gearwheel such that the second axis remains parallel to the first axis. In addition, the second gearwheel is biased towards the first gearwheel to partially intermesh therewith such that a variable gap is defined between the first and second gearwheel for passage of a continuous material.
Patent DE-69719195-T2 (DE)
Inventor: REBER H
IPC: B29C48/48
Filed: 1997-08-22
Granted: 2003-07-24
Abstract: A method for cascade, closed loop control of multiple operating parameters for an extrusion blow molding machine having multiple accumulators is disclosed. The method provides closed loop control of the ram back pressure during refill, along with the closed loop adjustment of the pressure set points for "slave" accumulators based on a comparison of ram positions with that of a "master" accumulator. For systems that supply each accumulator with a separate extruder, the rotational speed of the extruder screw is the controlled operating parameter during refill. With respect to extrusion of the parisons, there is closed loop control of the ram velocity in conjunction with adjustment of the velocity set points for the slave accumulators based on a comparison of ram positions with that of the master accumulator.
Patent DE-69724112-T2 (DE)
Inventor: BAXTER DOUGLAS
IPC: A61P25/00
Filed: 1997-04-04
Granted: 2004-06-03
Abstract: PCT No. PCT/GB97/00957 Sec. 371 Date Oct. 2, 1998 Sec. 102(e) Date Oct. 2, 1998 PCT Filed Apr. 4, 1997 PCT Pub. No. WO97/37973 PCT Pub. Date Oct. 16, 1997Compounds of formula (I) having MMP and TNF inhibitory activity.
Patent DE-69801449-T2 (DE)
Inventor: FALCON R
IPC: G06F9/445
Filed: 1998-11-16
Granted: 2001-12-06
Abstract: A method and system for configuring computers to connect to networks using network connection objects. For each connection to a network, configuration information for connecting to that network is maintained within a connection object. Such configuration information may include device, protocol, and other computer and network property information along with binding information therefor. Connection objects may be stored as files or the like independent of a running network configuration, and be applied to the running configuration to change the network configuration. Also included is a process to reconcile networking components identified in a connection object with those available on a given system.
Patent DE-69804081-T2 (DE)
Inventor: KATZ JOSEPH
IPC: B24C5/04
Filed: 1998-03-21
Granted: 2002-10-17
Abstract: A high speed fluid jet nozzle made at least in part of a porous material and configured so that the porous part of the nozzle is surrounded at least in part by a reservoir containing a lubricant fluid. As a cutting fluid passes through the nozzle, lubricant from the reservoir is drawn through the porous material and lubricates the surfaces of the nozzle exposed to the fluid jet. The invention not only resolves the main difficulties of the prior art relating to nozzle wear, it expands the use and applications of high speed fluid jet cutters. By reducing wear of a jet nozzle, it is possible to increase the jet speed and reduce the nozzle diameter even further than the prior art, allowing much higher precision, deeper cutting, and usage on difficult to cut material such as ceramics. The invention thus provides a reliable but yet very simple method for preventing nozzle wear.
Patent DE-69804294-T2 (DE)
Inventor: LENSELINK W
IPC: C07C43/188
Filed: 1998-07-27
Granted: 2002-10-02
Abstract: The invention is directed to novel compounds selected from the class of compounds having the structural formulae <CHEM> wherein the cyclohexane moiety with the dotted circle represents either a cyclohexane ring or a benzene ring, n represents an integer with the value 1, 3, or 4, m represents an integer with the value 1 or 2, R1, R2, R3, R4 and R5, represent hydrogen or a lower alkyl group, and the total carbon number of R1, R2, R3, R4 and R5 combined is eight or less.
Patent DE-69804496-T2 (DE)
Inventor: TURNER L
IPC: B65D17/34
Filed: 1998-11-24
Granted: 2002-11-14
Abstract: The product and method of manufacturing a tab having a rivet island window and adapted to be secured to a container end, including the steps of forming a first dimple at a first end position of the window and a second dimple at a second end position of the window, formed as depressed regions of metal residing outside the central plane of the metal. The method includes punching a first blank in the first dimple and a second blank in the second dimple, and subsequently bending the edge regions around the first and second blank to form a bend of the metal away from the central plane. The central region of the window is formed between and joining the blanks, and a rivet opening is formed, adapted to receive a rivet for staking the tab to a container end.
Patent DE-69807458-T2 (DE)
Inventor: DRYDEN RICHARD
IPC: B01D46/42
Filed: 1998-01-30
Granted: 2003-04-03
Abstract: A pressurized fluidized bed combustion system includes a pressure vessel, a furnace section within the pressure vessel for forming high temperature, high pressure gases and for generating steam, a compressor for providing compressed combustion air for the furnace section, a filter for cleaning the high temperature, high pressure flue gases formed in the furnace section, a gas turbine for generating power from the gases formed in the furnace section and cleaned in the filter, a steam turbine cycle for generating power from the steam generated in the furnace section, a heat recovery section, connected to the steam turbine cycle, for recovering heat from the gases exhausted from the gas turbine and for supplying the heat to feedwater provided for the steam generation in the furnace section, and an inlet duct for the filter. The inlet duct is connected between a gas discharge channel in the furnace section and a gas inlet channel in the filter. The inlet duct includes a first gas duct, a second gas duct, a first branch, connecting the gas discharge channel in the furnace section with the first and second gas ducts, for dividing the flow of gases from the furnace section into a first gas flow and a second gas flow, a second branch, connecting the first and second gas ducts with the gas inlet channel in the filter, for recombining the first and second gas flows and a gas cooler in the second gas duct for decreasing temperature of the second gas flow.
Patent DE-69807464-T2 (DE)
Inventor: GLAZIER ARNOLD
IPC: A61P31/22
Filed: 1998-05-15
Granted: 2003-05-15
Abstract: Disclosed are novel prodrugs represented by the following structural formula: Z is oxygen or sulfur; Y is, together with a hydroxy group, acyclovir or an analog of acyclovir; A is a substituted benzyl group with one or more protected hydroxy or protected amine groups in the ortho or para positions, relative to the phosphate ester, which can be converted in vivo to a hydroxy or amino group. Also disclosed is a method of treating a viral infection in an individual or animal. The method comprises administering to the individual or animal a therapeutically effective amount of a prodrug represented by structural formula shown above.
Patent DE-69809451-T2 (DE)
Inventor: SMITH ELIZABETH-SMITHKLINE BEE
IPC: B01J19/18
Filed: 1998-09-11
Granted: 2003-07-10
Abstract: A laboratory vessel comprising two substantially cylindrical chambers with parallel longitudinal axes between their bottom and mouth openings and lower and upper conduits linking the chambers so that he contents of the vessel can flow between the first and second chambers via the upper and lower conduits. The vessel is particularly suited for use with automated reactor systems.
Patent DE-69813585-T2 (DE)
Inventor: MCNALLY J
IPC: B29C33/36
Filed: 1998-08-19
Granted: 2004-03-04
Abstract: The mold press includes a drive arrangement for controlling press movement and closure force. The drive arrangement includes a pair of generally identical drive units connected between upper and lower press plates adjacent opposite longitudinal ends of the press. The drive units in a preferred embodiment each employ a ball-screw drive arrangement. The screw shaft extends vertically between the top and bottom press plates. The screw shaft engages a ball nut mounted on one press plate, typically the bottom press plate which is disposed for movement toward and away from the top press plate. A first high speed drive arrangement employing a first electric motor is coupled to the screw shafts for effecting high speed opening and closing of the bottom press plate. A second low-speed driving arrangement including a second electric motor is drivingly connected to the ball-nut assemblies for permitting low-speed but high-torque driving of the nut units for final closing of the press and application of the desired press force. Each drive unit has the screw shaft resiliently supported for limited axial displacement relative to the upper press plate so that, when the second drive system is activated to effect final closure of the mold, one or the other of the screw shafts can be axially displaced a small amount if necessary so as to permit full closure between the opposed upper and lower mold parts even though irregularities may cause one longitudinal end of the mold parts to contact and close prior to the other longitudinal end.
Patent DE-69813908-T2 (DE)
Inventor: WALLIMANN THEO
IPC: A61K31/205
Filed: 1998-07-28
Granted: 2004-02-05
Abstract: The method, composition, and use of the composition for healing defects in bone or cartilage tissue in animals and humans caused by trauma or surgery is disclosed. The method includes administration of creatine compounds including analogues or pharmaceutically acceptable salts thereof. Treatment in accordance with the method speeds-up time for and improves the process of healing of defects in bone or cartilage tissue in animals and humans caused by trauma or surgery including acceptance and bonding of artificial implants. The treatment with creatine compounds can be therapeutic for diseased patients, preventive for healthy people, as well as geriatric for elderly people.
Patent DE-69815518-T2 (DE)
Inventor: AMER M SAMIR
IPC: A61P17/02
Filed: 1998-01-23
Granted: 2004-04-22
Abstract: The 5HT2 receptor antagonizing effect of 2'-[2-(1-methyl-2-piperidyl) ethyl] cinnamanilide, a racemic mixture (R S-MPEC) of S-MPEC and R-MPEC isomers is found to be provided practically entirely by the S-MPEC isomer, the R-MPEC being effectively an impurity. Disclosed are pure S-MPEC, mixtures thereof with up to about 10% of R-MPEC, a novel method of resolving the S-MPEC involving a novel intermediate compound, therapeutic compositions containing S-MPEC, and uses thereof for administration to animals, especially humans, in need of 5HT2 receptor blockage, as for hemorrhoids, varicose veins, venous and coronary insufficiencies, wound healing, and as analgesic or local anesthetic agents.
Patent DE-69822818-T2 (DE)
Inventor: BOLL G
IPC: H01L21/66
Filed: 1998-05-20
Granted: 2005-02-03
Abstract: A probe for testing integrated circuits at microwave frequencies employs a tapered coaxial transmission line to transform the impedance at the probe tips to the impedance of the test instruments. Mechanically resilient probe tip structures allow reliable probing of non-planar circuits and the elastic probe body allows large overprobing without damage to the test circuit. Novel insulator structures for the coaxial line allow easy and accurate assembly and high performance.
Patent DE-69823650-T2 (DE)
Inventor: KOJIMA KOICHI
IPC: A61P35/00
Filed: 1998-02-26
Granted: 2004-12-09
Abstract: The compound of the following formula (I) is useful as a novel composition having an effect for treatment or prevention of prostate cancer. <CHEM> R<1>, R<2>: hydrogen atom, hydroxyl group or lower alkoxy group.
Patent DE-69823661-T2 (DE)
Inventor: MAEKELAE HELENA
IPC: A23L33/22
Filed: 1998-07-24
Granted: 2004-09-30
Abstract: The invention relates to a food preparation comprising a vegetal substance containing phyto-oestrogen, consisting of crushed flaxseed containing lignan and soya flour containing isoflavonoids. In addition, the preparation contains a fructo-oligosaccharide with a prebiotic effect, such as inulin. The phyto-oestrogen of the preparation is intended to act on menopause symptoms in women, and the purpose of fructooligosaccharide is to enhance intestinal activity by increasing the growth of Bifidobacteria in the intestines, thus promoting phyto-oestrogen conversion and absorption in the intestines. In accordance with the invention, the preparation is a mixture of components in the form of a solid, finely divided powder and groats, such as a mixture consisting of soya flour, crushed flaxseed, fructooligosaccharide and a flavouring and colouring vegetal substance, such as dried rosehip or lingonberry, and which can be mixed as such in a liquid to form a drink.
Patent DE-69825767-T2 (DE)
Inventor: HEATON PATRICK
IPC: A61B19/08
Filed: 1998-09-09
Granted: 2005-09-01
Abstract: This invention relates to surgical drapes and in particular provides a drape which comprises a thin, flexible, adhesive-coated plastics film and a protective, releasable layer applied to the adhesive coating, the drape having an aperture through at least the adhesive-coated film to permit, in use, access to a wound area, at least one first edge of the drape having a non-adhesive coated handling bar for separating the adhesive-coated film from the protective layer, and wherein the protective layer comprises a separate strip extending parallel to the first edge of the drape, and which protects the adhesive coating in the region of the aperture and carries at least one flap overlapping the adjacent portion of the protective layer, said flap constituting a handle for facilitating removal of said strip prior to use.
Patent DE-69826521-T2 (DE)
Inventor: COOK DAVID
IPC: C12N5/08
Filed: 1998-07-06
Granted: 2005-09-29
Abstract: Methods are provided for quenching undesired side reactions of pathogen inactivating compounds in biological materials comprising red blood cells. In a particular embodiment, methods are provided for quenching undesired side reactions of a pathogen inactivating compound that includes a functional group which is, or which is capable of forming, an electrophilic group. In this embodiment, the material is treated with the pathogen inactivating compound and a quencher, wherein the quencher comprises a nucleophilic functional group that is capable of covalently reacting with the electrophilic group. The electrophilic group on the pathogen inactivating compound is preferably a non-radical cationic group. In one embodiment, the pathogen inactivating compound includes a nucleic acid binding ligand and a mustard group, wherein the mustard group is capable of reacting in situ to form the electrophilic group. Preferred quenchers are thiols, such as glutathione. The methods permit inhibition of the modification of red blood cells in red blood cell containing materials during pathogen inactivation.
Patent DE-69826582-T2 (DE)
Inventor: CLARKSON CURTIS W
IPC: F16K3/02
Filed: 1998-07-23
Granted: 2005-10-06
Abstract: A packingless gate valve is disclosed which includes a housing (11) having opposed similar housing halves (30,32) with primary resilient sleeve units (53,54) which compressibly engage each other in the valve open condition and engage opposite sides of the gate in the valve closed condition. A secondary resilient seal unit (80) is positioned above the primary sleeve units (53,54) within the housing (11) and is secured between the housing halves (30,32). The secondary seal unit (80) engages the gate (14) during the opening and closing cycles and prevents any discharge seeping between the primary sleeves from leaking to the atmosphere around the gate (14) or on the actuator end of the valve. An enlarged clean out area (70) cast into the housing (11) extends circumferentially around the primary sleeve units (53,54) in one embodiment so as to provide containment for any discharge during an actuating cycle. The housing (11) is further provided with flush ports in fluid communication with the clean out area (70) to allow controlled draining or flushing of the contained slurry. The gate valve construction of the present invention results in no leakage to the outside when the valve is fully open and no leakage to the outside or past the gate (14) internally when the valve is fully closed. <IMAGE>
Patent DE-69829861-T2 (DE)
Inventor: FRIESEN RICHARD
IPC: C07D401/04
Filed: 1998-09-11
Granted: 2006-03-02
Abstract: The invention encompasses the novel compound of Formula (I) as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula (I).
Patent DE-69832099-T2 (DE)
Inventor: FRIEZE A
IPC: A61L2/14
Filed: 1998-08-26
Granted: 2006-09-21
Abstract: A flash sterilization container (10) comprises a pan (12) forming the bottom of the container holding a tray (14), with a cover (16) forming the top of the container, and a filter element (20). The filter (20) covers an opening in the cover (16) so that the inside of the container (10) formed when the cover is removably sealed to the pan (12) can communicate with the atmosphere surrounding the sealed container allowing steam to enter and exit the container passing through the filter (20). Items to be sterilized are placed on the tray (14) and the cover (16) is attached and sealed to the pan (12). The sealed container in then placed in an autoclave or other source of pressurized steam. The filter (20) allows the steam to enter the interior of the container and sterilize any items contained therein. After sterilization, the container (10) is removed from the autoclave and any remaining steam escapes from the interior of the container through the filter (20). The filter is composed of a material which will allow the pressurized steam to pass through but which is relatively impervious to dust and microorganisms thereby maintaining the sterility of the interior of the container and it's contents. Examples of suitable filter materials are: paper; TEFLON TM ; hydrophobic material, such as GORE-TEX TM ; porous stainless steel and polysulfone. The filter (20) can be held in place with a filter retainer manufactured as a permanent part of the cover (16) or incorporated into a filter cartridge which is removably attached to the cover.